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Objective: It has been reported that interleukin (IL)-10 limits blood-induced cartilage damage. Our aim
was to study the effect of IL-4 alone and in combination with IL-10 on blood-induced cartilage damage.
Design: Healthy human full thickness cartilage explants were cultured for 4 days in the presence of 50%
v/v blood. IL-4, IL-10, or a combination of both cytokines was added during blood exposure. Cartilage
matrix turnover was determined after a recovery period; additionally cytokine production, chondrocyte
apoptosis, and expression of the IL-4 and IL-10 receptors were analyzed directly after exposure.
Results: Blood-induced damage to the cartilage matrix was limited by IL-4 in a dose-dependent way
(P< 0.05). Also IL-10 limited this damage, although to a lesser extent (P< 0.03). The effect of IL-4 plus IL-
10 was more pronounced and protective than IL-10 alone (P< 0.05). Production of IL-1b and tumor
necrosis factor (TNF)-a was limited by both IL-4 and IL-10 (P< 0.05), but more strongly by IL-4. Blood-
induced apoptosis of chondrocytes was limited by IL-4 and the combination, and not by IL-10 alone. No
direct beneﬁcial effect of IL-4 or IL-10 on cartilage was found, however, the chondrocyte receptor
expression of both cytokine receptors was upregulated by exposure to blood.
Conclusions: This study demonstrates that IL-4 alone and in combination with IL-10 prevents blood-
induced cartilage damage. Expectedly, anti-inﬂammatory effects on monocytes in the blood fraction
and protective effects on chondrocytes are both involved. IL-4 in combination with IL-10 might be used
to prevent blood-induced joint damage as a result of trauma or surgery.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
A joint bleed can occur during joint surgery, as a result of joint
trauma, and in patients suffering from bleeding disorder such as
hemophilia. Joint bleeds, forwhatever cause, are expected to lead to an
inﬂammatory response in the joint and todestructionof joint cartilage,
the latter both directly as well as indirectly via inﬂammation1,2.
Natural evacuation of blood from the joint cavity leads to
deposition of iron in the synovial tissue, resulting in proliferation,
hypertrophy, ﬁbrosis, and neovascularization3. This inﬂammation
of synovial tissue contributes to cartilage damage4. Recently it hasM.E.R. van Meegeren, Rheu-
enter Utrecht, Room F.02.127,
31-88-755-1770; Fax: 31-33-
l (M.E.R. van Meegeren).
s Research Society International. Pbeen demonstrated that experimentally induced joint bleeds in
hemophilic mice lead to rapid elevation of pro-inﬂammatory
cytokines like interleukin (IL)-1b, IL-6, and keratinocyte-derived
chemokine (KC; functional murine IL-8 homologue) in the syno-
vial ﬂuid5, supporting the existence of an inﬂammatory synovial
component in the pathogenesis of blood-induced joint damage.
These released cytokines will have their repercussion on cartilage
integrity, as it is known that especially IL-1 and tumor necrosis
factor (TNF) are major players in cartilage degeneration6.
There is also a direct harmful effect of blood on cartilage.
Previous in vitro research has shown that a single blood-exposure
of cartilage can lead to long-lasting, irreversible damage7. Mono-
cytes/macrophages and red blood cells, as present in blood, are
responsible for irreversible inhibition of matrix synthesis8. It is
proposed that after a joint bleed, iron-containing hemoglobin is
released by damage or phagocytosis of red blood cells. Small
amounts of IL-1b, produced by activated monocytes/macrophages,
increase production of hydrogen peroxide by chondrocytes. This, inublished by Elsevier Ltd. All rights reserved.
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formation of hydroxyl radicals in the vicinity of chondrocytes,
resulting in chondrocyte apoptosis and with that irreversible
inhibition of cartilage matrix synthesis9,10.
The devastating effects of blood in a joint may be ameliorated
by treatment with medication. Immunosuppressive cytokines, like
IL-4 and IL-10, could be candidates to protect joints from
thedamagingeffects of blood-exposure. IL-4 binds to themultimeric
IL-4 receptor (IL-4R) consisting of a primary subunit IL-4Ra
associated with a common gamma chain (gc or IL-2R) and/or
IL-13Ra’ subunit (also known as IL-13Ra1)11,12. IL-4 inhibits
production of IL-1b and TNF-a by stimulated synovial ﬂuid mono-
nuclear cells13. In animal models of inﬂammatory arthritis IL-4
inhibits cartilage andbonedegradation aswell as inﬂammation14e17.
IL-10 binds to the tetrameric IL-10 receptor (IL-10R), consisting
of two IL-10R1 chains and two IL-10R2 chains18. IL-10 is able to
stimulate intrinsic immunoregulatory activity. It inhibits produc-
tion of IL-1b and TNF-a by activated macrophages19,20 and RA
synovial tissue21,22 in vitro, limits production of metalloproteinase
by mononuclear cells, and stimulates production of their inhibitor
(tissue inhibitor of metalloproteinases; TIMP-1)23. In experimental
arthritis models IL-10 ameliorates arthritis and joint destruc-
tion15,24. In addition to beneﬁcial effects in rheumatoid- and oste-
oarthritis, IL-10 also protects cartilage from blood-induced damage
in terms of cartilage matrix turnover in vitro. Moreover, IL-10
beneﬁcially affects cartilage and synovial tissue from patients
with hemophilic arthropathy25. However, blood-induced cartilage
damage is not fully prevented by IL-1025.
IL-4 and IL-10 use different signaling pathways; IL-4 inhibits
cytokine messenger RNA (mRNA) accumulation in monocytes by
enhancingdegradationofmRNA,while IL-10 inhibits cytokinemRNA
accumulation in monocytes by inhibiting nuclear localization of
nuclear factor kappa B (NFkB)26. Because IL-4 and IL-10 use different
signaling pathways, they are able to exert different, but also poten-
tially additive effects. It has been reported that IL-10 acts synergis-
tically with IL-4 in suppressing macrophage cytotoxic activity27 and
production of IL-1 receptor antagonist by human neutrophils28.
Moreover, the combination of IL-4 and IL-10 has an additive effect on
inhibition of IL-1b and TNF-a production by antigen stimulated
mononuclear cells from the synovial ﬂuid and peripheral blood from
patients with rheumatoid arthritis29. Therefore, in the present study
the protective effect of IL-4 alone and in combination with IL-10 on
blood-induced cartilage damage was studied.
Materials and methods
Cartilage culture technique
Healthy human articular cartilage tissue was obtained post
mortem from humeral heads within 24 hours after death of the
donor, according to the medical ethical regulations of the Univer-
sity Medical Center Utrecht. The donors (n¼ 14, mean age
66.8 3.1 years, 7 males and 7 females) had no known history of
joint disorders. Full thickness slices of cartilage were cut aseptically
from the humeral head, excluding the underlying bone, and kept in
phosphate-buffered saline (PBS, pH 7.4). Within 1 hour after
dissection, slices were cut in small full thickness cubic explants and
weighted aseptically (range 5e15 mg, accuracy 0.1 mg). The
explants were cultured individually in a 96-wells round-bottomed
microtiter plate (at 5% CO2 in air, pH 7.4, 37C, and 95% humidity).
Culture medium consisted of Dulbecco’s Modiﬁed Eagle’s Medium
(DMEM; Invitrogen) supplemented with glutamine (2 mM), peni-
cillin (100 IU/mL), streptomycin sulphate (100 mg/mL; all PAA),
ascorbic acid (85 mM; Sigma), and 10% heat inactivated pooled
human male ABþ serum (Gemini Bioproducts).Experimental design
For each experiment, fresh blood was drawn from healthy
human donors (n¼ 14, mean age 25.8 0.5 years, 8 males and 6
females) in a vacutainer tube (nr. 367895; Becton Dickinson). To
mimic a human joint bleed, cartilage was exposed to 50% v/v whole
blood for 4 days, which is considered to be the natural evacuation
time of blood from the joint cavity30e32. After blood-exposure,
cartilage explants were washed twice under culture conditions
for 45 min to remove all additives and were cultured for an addi-
tional 12 days. Medium was refreshed every 4 days.
In the ﬁrst set of experiments, the effects of IL-4 on blood-
induced cartilage damage were determined by addition of IL-4 to
the blood cartilage co-culture in a concentration of 1, 3, 10, 30, and
100 ng/mL during blood-exposure. Experiments were performed
with cartilage of ﬁve independent donors and blood of ﬁve inde-
pendent donors (n¼ 5). Previously, it was shown that IL-10 limits
blood-induced cartilage damage, using 10 ng/mL as an optimal
concentration25.
In the second set of experiments IL-4 was added in addition to
IL-10 (both 10 ng/mL; Sigma) and compared to the effect of IL-10
alone on blood induced cartilage damage. The experiments were
performed in n¼ 9 with cartilage of nine independent donors and
blood of nine independent donors.
Thirdly, in order to determinewhether IL-4 and IL-10 have direct
beneﬁcial effects on cartilage, explants were cultured for 4 days in
the presence of 10 ng/mL IL-10, IL-4 or a combination of the two
cytokines in the absence of blood (ﬁve independent cartilage
donors; n¼ 5).
Determination of proteoglycan (PG) turnover
As a measure of PG synthesis rate the sulfate incorporation rate
into glycosaminoglycans (GAGs) was determined. At the end of
each experiment 74 kBq Na235SO4 (NEX-041-H carrier free; DuPont)
was added per well. After 4 hours of pulse labeling of the newly
formed sulfated GAGs, cartilage samples werewashed twice in cold
PBS and stored at 20C. Thawed samples were digested for 2
hours at 65C with 2% papain (Sigma). PG synthesis rate was
determined by precipitation of GAGs with 0.3M hexadecylpy-
ridinium chloride monohydrate (CPC; Sigma) in 0.2M NaCl. The
precipitate was dissolved in 3M NaCl and the amount of radioac-
tivity was measured by liquid scintillation analysis. Radioactive
counts were normalized to the speciﬁc activity of the medium,
labeling time, and wet weight of cartilage. Results were expressed
as moles of sulfate incorporated per gram wet weight of cartilage
tissue (nmol/h*g).
PG content of each cartilage explant and release of PGs into
culture medium of the ﬁrst 4 days were established by staining and
precipitation of GAGs with Alcian Blue (Sigma). Staining was
quantiﬁed by absorptiometry at 620 nm using chondroitin sulfate
(Sigma) as a reference. Results were expressed as mg GAG per wet
weight of cartilage tissue (mg/g) and mg GAG released during 4
days per wet weight of tissue (mg/g).
Because of focal differences in composition and bioactivity of the
cartilage, PG turnover parameters were determined of 10 cartilage
explants (10 replicates) of the same donor, obtained randomly and
handled individually. The average of these 10 samples was taken as
a representative value for that cartilage donor.
Enzyme-linked immunosorbent assay (ELISA)
To investigatewhether IL-4 and IL-10had an effect onproduction
of pro-inﬂammatory cytokines, cartilage explants were cultured for
4days in absenceor presenceof 50%blood, and10 ng/mL IL-4 and/or
Table I
Properties of RT-PCR primers
Receptor
subunit
Primer Melting
temperature
(C)
Product
(bp)
IL-4Ra Fwd 50-GGAAGAGGGGTATAAGCCTTT-30 53 570
0 0
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and TNF-a were determined in singlicate in culture supernatants
after 1e2 hours of culture, and after 1, 2, 3, and 4 days. Commercially
available ELISA cytosets (Biosource) were used and the analyses
were performed according to the manufacturer’s protocol. Data are
expressed in pg/mL.Rev 5 -CACGGAGACAAAGTTCACGAT-3
IL-13Ra’ Fwd 50-AACTCGTCGTTCAATAGAAG-30 55 454
Rev 50-TGTGGAGGATCAGGTTTCACACGG-30
gc Fwd 50-CTCCTTGCCTAGTGTGGATGG-30 60 345
Rev 50-CACTGTAGTCTGGCTGCAGAC-30
IL-10R1 Fwd 50-CCATCTTGCTGACAACTTCC-30 60 440
Rev 50-GTGTCTGATACTGTCTTGGC-30
b-actin Fwd 50-CCAAGGCCAACCGCGAGAAGATGAC-30 60 579
Rev 50-AGGGTACATGGTGGTGCCGCCAGAC-30Immunohistochemistry
For immunohistochemical detection of chondrocyte apoptosis
anti-single strand DNA monoclonal antibody (clone F7-26; Alexis)
was used. Three human cartilage explants of a single donor were
exposed to 50% v/v whole blood of a single donor for 4 days with or
without10 ng/mL IL-4, IL-10or IL-4plus IL-10. Subsequentlycartilage
explantswere harvested andﬁxed in 4% formalin at 4C for 24 hours.
Fixed samples were dehydrated with absolute ethanol, prepared
with xylene and embedded in parafﬁn. Sections (4 mm) were cut,
deparafﬁned, and rehydrated in PBS. Tissue was permeabilized with
0.2 mg/mL saponin (Sigma) and treated with 20 mg/mL proteinase K
(Roche). Slides were heated to 56C in formamid to denature
unstable DNA and subsequently transferred to ice-cold PBS. The
sections were incubatedwith anti-ssDNA antibody and the antibody
complex was visualized using 3,3’-diaminobenzidine (DAB; Vector).
The tissue was counterstained with hematoxylin. The amount of
brown-positive stained cells and the total number of chondrocytes
were counted, excluding empty lacunae. Per cartilage explant the
average counted area was 1.47 mm2. Data are expressed as
percentagepositive cells of the totalnumberof chondrocytes for each
of the 3 cartilage explants separately.RNA isolation and reverse transcription polymerase chain reaction
(RT-PCR)
To investigate whether blood exposure can alter IL-4/10
receptor expression on chondrocytes, human cartilage of three
independent donors was cultured for 4 days with or without
exposure to 50% v/v blood (of three independent donors; n¼ 3).
After 4 days cartilage was washed and snap-frozen. Total cellular
RNA was extracted using a tissue homogenizer (ART’s Miccra D-1)
and Qiagen RNeasy Lipid tissue mini kit. About 100 mg cartilage
was crushed in Qiazol to maintain RNA integrity and break down
cells and cell components. RNA was isolated according to manu-
facturer’s instructions.
RT-PCRwas performed using the GeneAmp PCR Core Kit (Roche)
according to the manufacturer’s protocol. Brieﬂy, an equal amount
of RNA per cartilage donor, varying from 44 to 90 ng, was reverse
transcribed using random hexamers as primers. An extensive
region was ampliﬁed from IL-4Ra, IL-13Ra’, gc, IL-10R1, and b-actin
cDNA, using 30 pmol of the corresponding primers. These were
adopted from Guicheux et al. (IL-4Ra, IL-13Ra’, gc, and b-actin)33 or
from Lysa et al. (IL-10R1)34 (Table I). The samples of IL-4Ra, IL-13Ra’,
gc, and b-actin were heated for 5 min at 95C and subjected to 35
cycles of ampliﬁcation (denaturation at 94C for 60s; annealing at
53C, 55C, 60C, and 60C, respectively, for 90s; and extension at
72C for 60s), followed by an elongated extension step of 10 min
after the last cycle. For IL-10R1, samples were heated for 5 min at
95C and subjected to 30 cycles of ampliﬁcation (denaturation at
94C for 60s; annealing at 60C for 90s; and extension at 72C for
60s), followed by an elongated extension step of 10 min after
the last cycle. Controls without RNA and controls in which the
reverse transcription step was omitted were included. As a positive
control mRNA of the mononuclear cell line U937 was included.
Subsequently, the PCR products were subjected to agarose gel
electrophoresis.Calculations and statistical analyses
Results are depicted as median values of individual experiments
(viz. independent cartilage and blood donors), except for the
immunohistochemistry experiment that was performed in tripli-
cate with cartilage and blood of single donors. The data were
analyzed using a non-parametric test for related samples (Wil-
coxon signed rank test) with SPSS 15.0 software. Differences were
considered to be statistically signiﬁcant when P 0.05.
Results
IL-4 prevents blood-induced cartilage damage in a dose-dependent
way
Exposure of cartilage explants to 50% v/v whole blood for 4 days
led to an impaired turnover of PGs; one of the major components of
articular cartilage. After blood-exposure PG synthesis rate was
decreased by 58%, PG release was increased by 73%, and total PG
content was reduced by 15% (all P¼ 0.04; ﬁrst dot [Fig. 1(AeC)],
respectively).
Addition of IL-4 in a concentration ranging from 1e100 ng/mL
during the 4 day blood-exposure resulted in a dose-dependent
recovery of PG synthesis rate to complete normalization (compared
to cartilage that was exposed to 50% v/v blood; at all concentrations
P¼ 0.04). PG release demonstrated normalization already at the
lowest concentration of IL-4 and this remained over the entire
concentration range (at all concentrations P¼ 0.04 compared to
blood-exposed cartilage). Also PG content normalized by addition of
IL-4 (from 1 up to 30 ng/mL; P¼ 0.04 compared to blood-exposure).
IL-4 plus IL-10 is more potent than IL-10 alone
Addition of 10 ng/mL IL-10 during exposure of cartilage to 50% v/v
blood for 4 days showed similar effects as reported previously25; it
prevented downregulation of the PG synthesis rate at day 16 by 41%
compared to cartilage that was exposed to blood only (P¼ 0.03;
[Fig. 2(A)]). Exposure of cartilage to blood in the presence of 10 ng/mL
IL-4 resulted in even better recovery fromblood induced inhibition of
PG synthesis (125% increase compared to blood alone; P¼ 0.01).Most
importantly, IL-4 aswell as the combination of IL-4 and IL-10 resulted
in a normalization of PG synthesis, the effect of IL-4 in addition to
IL-10 being statistically signiﬁcantly better than that of IL-10 alone
(P¼ 0.01).
PG release was diminished by 42% [P¼ 0.01; Fig. 2(B)] upon
addition of IL-10 when cartilage was cultured with 50% blood.
Addition of IL-4 led to an even further decrease of PG release (59%
decrease compared to blood alone, P¼ 0.01). Moreover, IL-4 added
to IL-10 reduction of PG release (P¼ 0.01).
Fig. 1. IL-4 prevents blood-induced cartilage damage dose-dependently. Human articular cartilage was exposed to 50% v/v whole blood for 4 days, except control cartilage (con).
IL-4 was added in a concentration of 1, 3, 10, 30, and 100 ng/mL during blood-exposure. PG synthesis rate (A), -release (B), and -content (C) were determined. Each dot represents an
independent cartilage and blood donor (n¼ 5); dashes represent the median value. Asterisks indicate a statistical signiﬁcant difference (P 0.05).
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lage was treated with IL-10 [16% increase compared to blood alone;
P¼ 0.03; Fig. 2(C)], resulting in normalization. Also addition of IL-4,
as well as the combination of IL-4 and IL-10, enhanced PG content
of cartilage exposed to blood (16% and 15% increase; P¼ 0.01 and
P¼ 0.05, respectively).
Production of pro-inﬂammatory cytokines is limited by IL-4 and IL-10
At the start of co-culture of cartilage and blood, as well as during
a 4-day cartilage culture in absence of blood, almost no IL-1b or
TNF-a was detected in the culture supernatants [Fig. 3(A and B);
day 0 and control].
Co-culture of cartilage and 50% blood led to a statistically
signiﬁcant increase of IL-1b concentration when compared to
control levels [Fig. 3(A); all P¼ 0.01 at day 1e4]. Production of IL-1b
was suppressed by IL-10 at all time points (all P¼ 0.01 when
compared to blood), and fully prevented by IL-4 and by a combi-
nation of IL-4 plus IL-10 (all P¼ 0.01 when compared to blood).
Moreover, addition of IL-4 or IL-4 plus IL-10 decreased IL-1b levels
even more when compared to IL-10 alone (all P< 0.02 at day 1e4);
IL-10 alone still being statistically signiﬁcant elevated compared to
controls without blood (P< 0.02 at day 0e3).
Another important cytokine in cartilage degeneration, TNF-a,
was signiﬁcantly increased in cultures with 50% blood [Fig. 3(B); all
P< 0.02 when compared to control at day 1e4]. TNF-a production
was suppressed by IL-4, IL-10, and a combination of IL-4 plus IL-10at day 1e4 (all P< 0.02 when compared to blood), although TNF-a
levels were still statistically signiﬁcant higher than controls (all
P< 0.05 at day 1e4).
IL-4 and the combination of IL-4 plus IL-10 limit blood-induced
apoptosis of chondrocytes
It has been shown that IL-1b in combination with lysed eryth-
rocytes causes hydroxyl radical formation and with that apoptosis
of chondrocytes9. Since production of IL-1b and TNF-awere limited
by IL-4 and IL-10, it was tested whether this also resulted in limi-
tation of blood-induced apoptosis of chondrocytes. Exposure of
cartilage to blood for 4 days led to apoptosis of 43% of the chon-
drocytes compared to 3% when cartilage was cultured in medium
without additives [Fig. 4(B and A), respectively]. It appeared that
blood-induced apoptosis of chondrocytes was only marginally
reduced by the addition of IL-10 [Fig. 4(C); still 37% positive cells].
Similar to the effects on PG turnover and IL-1b production, IL-4 was
more potent than IL-10 and lowered the amount of apoptotic cells
clearly [Fig. 4(D); 3% positive cells remaining]. Also the combination
of the two cytokines obviously decreased the amount of blood-
induced apoptotic cells [Fig. 4(E); 10% positive cells].
No direct beneﬁcial effects of IL-4 and/or IL-10 on healthy cartilage
Besides the beneﬁcial effects of IL-4 and IL-10 on blood-induced
cartilage damage, it was tested whether they had direct beneﬁcial
Fig. 2. IL-4 and/or IL-10 prevent blood-induced cartilage damage. Human articular cartilage was exposed to 50% v/v whole blood for 4 days. IL-4 and IL-10 were added in
a concentration of 10 ng/mL during blood-exposure. PG synthesis rate (A), -release (B), and -content (C) are depicted. Each dot represents an independent cartilage and blood donor
(n¼ 9); dashes represent the median value. Asterisks indicate a statistical signiﬁcant difference (P 0.05).
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nation of IL-4 plus IL-10 slightly increased PG content, although not
statistically signiﬁcant (Table II). In general, IL-4 and IL-10 did not
have statistically signiﬁcant direct beneﬁcial effects on cartilage PG
turnover in the absence of blood.
Upregulation of IL-4R and IL-10R after blood-exposure
A possible explanation for the lack of direct effects of IL-4 and
IL-10 on cartilage could be lack of sufﬁcient receptor expression.
Figure 5 depicts mRNA expression of the IL-4 and IL-10 receptors
and of the housekeeping gene b-actin on cartilage explants with
and without 4 days exposure to blood. It appeared that mRNA
expression of two subunits of the IL-4R (IL-4Ra and IL-2Rg) was
upregulated after blood-exposure in three different cartilage
donors. Also mRNA expression of IL-10R1 was increased after
exposure to blood, indicating that receptor expression for both IL-4
and IL-10 is increased after blood-exposure of cartilage. As such,
this could explain the fact that IL-4 and IL-10 do not have direct
beneﬁcial effects on cartilage that is not exposed to blood.
Discussion
This study shows for the ﬁrst time that IL-4 is able to prevent
blood-induced cartilage damage in a dose-dependent way, and
more potently than it has been previously reported for IL-1025. At
higher concentrations of IL-4, cartilage matrix turnover isnormalized after blood-exposure. Moreover, it was shown that IL-4
plus IL-10 has an additional protective effect on blood-induced
cartilage damage compared to IL-10 alone regarding PG synthesis
rate and -release. Both IL-4 and IL-10 inhibit production of the pro-
inﬂammatory cytokines IL-1b and TNF-a, again IL-4 being more
effective, whereas only IL-4 and the combination of IL-4 plus IL-10
prevent chondrocyte apoptosis. No long-lasting direct effects of IL-4
and IL-10 on healthy cartilage were found, which was explained by
the low expression of IL-4 and IL-10 receptors on chondrocytes.
After exposure of cartilage to blood, these receptors were upregu-
lated, providing a potential secondary direct effect on cartilage.
The effect of the combination of IL-4 in addition to IL-10 was
statistically signiﬁcantly different from the effect of IL-10 alone, but
not compared to the effect of IL-4 alone. Apparently in equal
concentrations the effect of IL-4 is stronger than that of IL-10 and as
such can overcome the effect of IL-10, but not the other way around.
It might well be that IL-10 still adds to the effect of IL-4 in case IL-4
concentrations are lower than that of IL-10, but this needs further
study. Nevertheless, the use of IL-4 plus IL-10 instead of IL-4 alone
may be essential in case of clinical application. It was shown that
adenoviral vector-mediated overexpression of IL-4 in collagen-
induced arthritis mice leads to prevention of chondrocyte death,
a reduction in cartilage erosions, and improvement of inhibition of
PG synthesis. However, also synovial inﬂammation was enhanced
because of exposure to high levels of IL-4 (approximately 400 pg/
mL measured 7 days after injection of the vector)16. This could be
explained by the fact that IL-4 is able to attract macrophages,
Fig. 3. IL-4 and IL-10 limit production of pro-inﬂammatory cytokines in blood cartilage co-cultures. Cartilage in the absence and presence of 50% v/v whole blood was cultured for
a period of 4 days. IL-4 and IL-10 were added in concentrations of 10 ng/mL. The concentration of IL-1b (A) and TNF-a (B) produced during culture, was measured 1e2 hours after
blood collection (day 0), and after 1, 2, 3, and 4 days of culture. At day 1e4, addition of IL-4, IL-10, and the combination led to a statistically signiﬁcant decrease of median IL-1b and
TNF-a concentrations when compared to untreated blood cartilage co-cultures (all P 0.05; not indicated). Asterisks indicate a difference with control values (P 0.05, n¼ 8
independent cartilage and blood donors); for IL-1b only present for blood without addition or blood with IL-10 addition, and for TNF-a present for all conditions.
Fig. 4. IL-4, but not IL-10, prevents apoptosis of chondrocytes after exposure to blood. Human articular cartilage explants were cultured in medium (A) or exposed to 50% v/v whole
blood (B-E) for 4 days. IL-10 (C), IL-4 (D), or a combination of these cytokines (E) was added in a concentration of 10 ng/mL during blood-exposure. Each condition was performed in
triplicate with cartilage and blood of a single donor. Apoptosis of chondrocytes was determined by immunohistochemical staining with ssDNA (brown staining indicated by arrow)
and was expressed as a percentage of all stained cells (F). Slides of each of the cartilage explants were scored by two blinded observers. Each dot represents the average of the two
observers; dashes represent the mean value. Original magniﬁcation: 40.
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Table II
No statistically signiﬁcant direct effects of IL-4 and IL-10 on cartilage explants
Control 10 ng/mL IL-10 10 ng/mL IL-4 10 ng/mL
IL-4 & IL-10
PG synthesis rate 3.9
(3.8e5.2)
5.5
(2.6e5.6)
4.4
(3.6e5.8)
4.1
(3.8e5.2)
PG release 0.9
(0.4e1.9)
1.0
(0.5e1.7)
1.0
(0.5e1.9)
1.1
(0.5e1.8)
PG content 16.5
(12.4e19.6)
16.8
(13.8e17.8)
16.8
(13.8e21.0)
19.0
(14.2e21.5)
PG parameters (in absence of blood) are expressed as median with interquartile
range (n¼ 5 independent cartilage donors).
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sure to high levels of IL-4 can lead to accumulation of tissue
macrophages and increased erythrophagocytosis in liver, spleen,
and bone marrow of mice36. It is also known that IL-4 is crucial for
full development of arthritis in K/BxN mice37, indicating that high
levels of IL-4 could be harmful to the joint. When IL-4 is combined
with IL-10, a better balance between the Th1 and Th2 response is
achieved38. This could result in less inﬂammation of synovial tissue,
maintaining the protective effects of IL-4 on cartilage29.
This in vitro study showed that IL-4 and IL-4 plus IL-10 can almost
fully prevent blood-induced cartilage damage in a culture system
without involvement of surrounding tissues like synovial tissue.
However, inﬂamed synovial tissue contributes to joint and cartilage
damage in vivo39. We assume that IL-4 and IL-10 have even more
beneﬁcial effects in vivo, since it is known that IL-4 and IL-10 regulate
inﬂammation in arthritis models and rheumatoid synoviocytes40,41.
Synovitis is characterized by an increase in proangiogenic factors and
vascularity42,43. IL-4 is able to reduce these proangiogenic factors and
to directly inhibit angiogenesis in synovial tissue of rat adjuvant-
induced arthritis44. Furthermore, IL-4 limits Vascular endothelial
growth factor (VEGF) production by ﬁbroblasts derived from rheu-
matoid arthritis patients. Moreover, the combination of IL-4 plus
IL-10 limited VEGF production even more than each of the cytokines
alone45. As such, besides beneﬁcial effects on cartilage upon blood
exposure, IL-4 and IL-10 could additionally reduce synovitis when
administered in vivo.Fig. 5. Cartilage upregulates mRNA expression of IL-4R and IL-10R after exposure to
blood. Human articular cartilage (n¼ 3 independent cartilage and blood donors) was
exposed to 50% v/v whole blood for 4 days. Cartilage (100 mg) was crushed and
mRNA was isolated. A RT-PCR reaction was performed for subunits of the IL-4 receptor
(IL-4Ra, gc, and IL-13Ra’), for the IL-10 receptor (IL-10R1), and for b-actin as a house-
hold gene. As a positive control mRNA of the mononuclear cell line U937 was included.This study also showed that IL-4 and the combination of IL-4 plus
IL-10 reduce blood-induced apoptosis of chondrocytes, while IL-10
alone does not. This is in contrast with literature demonstrating
that IL-10 limits TNF-a-induced apoptosis of serum-starved human
articular chondrocytes as measured by caspases activation46.
However, in those experiments serumdeprivationwas needed as an
additional apoptotic stimulus for TNF-a, whereas in this study the
trigger for apoptosis is exposure to blood. Another study showed
that pretreatment of chondrocyteswith a high concentration of IL-4
could not prevent apoptosis of chondrocytes by IL-1b and TNF-a47.
This is also in contrast with the results of our study.
It is known that the capacity of IL-4 to act on chondrocytes
depends on the differentiation status of the chondrocyte and
thereby on the expression patterns of IL-4R subunits33. Our study
shows that chondrocytes cultured in a cartilage explant for 4 days
express only two out of three subunits of the IL-4R; gc and IL-13Ra’.
After 4 days exposure to blood, both mRNA of the IL-4Ra and gc
subunit are upregulated, while IL-13Ra’ remains equally expressed.
Also IL-10R1 expression is upregulated after blood-exposure. This
could explain that IL-4 plus IL-10 is able to limit blood-induced
cartilage damage, but does not have direct beneﬁcial effects on
healthy cartilage matrix turnover itself. The question remains how
long a higher expression of IL-4R and IL-10Rwill last andwhether it
enables direct beneﬁcial effect on cartilage after blood exposure.
However, since blood exposure causes apoptosis of 43% of the
chondrocytes, it is assumed that exposure of cartilage to IL-4 and
IL-10 after a bleed is not capable to restore the cartilage damage. On
the other hand, up-regulation of receptors on the remaining viable
chondrocytes might result in sustained effects of IL-4 and IL-10.
This study showed that IL-4 and IL-10 are able to normalize
production of IL-1b and TNF-a in a blood-cartilage co-culture. Culture
of blood alone produces the same amounts of IL-1b and TNF-a as
measured in a co-culture of blood and cartilage (data not shown),
indicating that the majority of IL-1b and TNF-a in a co-culture is
produced by monocytes in the blood fraction instead of by chon-
drocytes in the cartilagematrix. Therefore it is assumed that IL-4 and
IL-10 act for a large part via monocytes in the blood fraction through
inhibition of pro-inﬂammatory cytokines. It seems that cartilage is
protected by a change of the blood culture characteristics. However,
IL-4 and IL-10 probably also act via chondrocytes, because the
receptors for both cytokines are upregulated after blood exposure.
In conclusion, this study shows that IL-4 alone and in addition to
IL-10 protects against blood-induced cartilage damage. Expectedly,
anti-inﬂammatory effects on monocytes in the blood fraction and
protective effects on chondrocytes are both involved. As such, IL-4
in combination with IL-10 might be used to prevent and treat
blood-induced joint damage as a result of trauma or surgery.
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